Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > April 2015

« Previous month Next month »

IBEF: India still attractive for Japanese pharma despite Daiichi Sankyo's Ranbaxy experience

30-Apr-2015 - Japanese drug firms eyeing international investments should not be put off by Daiichi Sankyo’s turbulent ownership of Ranbaxy according to an Indian delegation in Tokyo last week to seek collaborations....


Favourite for Novo Nordisk CEO suddenly quits

30-Apr-2015 -

India’s ambition to bring home API manufacture

30-Apr-2015 - The Indian government has announced a scheme to boost home-grown production of APIs and bulk finished drugs.  

Catalent and 3M stress the importance of being bioavailable

30-Apr-2015 - [View the story "Bracknell hosts earnest drug delivery tech discussion" on Storify]

FDA’s Woodcock calls to cut clinical costs via new efficiencies

30-Apr-2015 - As the cost of clinical trials continues to grow, Janet Woodcock, director of the Center for Drug Evaluation and Research at the FDA told Senators earlier this week that there...

MHLW says PIC/S membership means high quality drugs will get to patients faster

29-Apr-2015 - Japan’s membership of the PIC/S international inspection and manufacturing scheme bodes well for patients in Japan and elsewhere according to the Ministry of Health, Labour and Welfare and Pharmaceuticals and...


Regulators: skip clinical data and extrapolate biosimilar indications

29-Apr-2015 - Sponsors can license biosimilars for multiple indications without performing clinical studies for each area, the EMA and FDA agree.

Amgen expands hiring in Massachusetts as other facilities close more quickly

29-Apr-2015 - Biotech giant Amgen has begun hiring about 100 more research scientists and production engineers as part of an expansion at its office in Cambridge, Massachusetts at the same time as...

WHO: Pharmas should give cash not drugs to aid Nepal earthquake relief efforts

28-Apr-2015 - Drug companies that want to support aid efforts in Nepal should donate cash rather than medicines according to the World Health Organisation (WHO).

Allergan and Hospira recalls

28-Apr-2015 - Hospira has recalled one lot of the anaesthetic Bupivacaine after a customer discovered orange and black particles floating and embedded in a glass vial.

Mylan rejects $40bn bid, questions Teva’s credibility

28-Apr-2015 - Mylan has rejected an unsolicited bid by Teva and upped its offer for Perrigo, as the ongoing saga in the generics space continues.

News from CPhI Japan

Sakigake: New Japanese drug laws will foster global innovation says MHLW

28-Apr-2015 - ‘Epoch making’ revisions to Japanese drug laws have provided a pathway for development of safer, more innovative drugs according to MHLW director, Haruo Akagawa.

News from CPhI Japan

Generic firms still face brand loyalty challenge in Japan say experts

27-Apr-2015 - Generic drug use in Japan has started to increase but 'brand loyalty' is still a considerable challenge according to industry experts.

Foreign particles lead Mylan to recall lots of cancer injectables

27-Apr-2015 - Mylan has recalled eight lots of injectables after foreign particulate matter was observed during the testing of samples.

People on the Move

UN appoints new Ebola head

27-Apr-2015 - And microbiology awards to research scientists and Médecins Sans Frontières.

Special from BPI Europe 2015

Eliminating fear culture can save operational costs and jobs, says Pfizer

23-Apr-2015 - Pfizer reduced costs 40% without cutting jobs at a facility in Sweden using an alternative approach to organisational and cultural behaviour, and hopes to do the same at its newly acquired Austrian...

Agilent unveils Q-TOF system for routine analyses

23-Apr-2015 - Agilent Technologies has launched a quadrupole-time of flight (Q-TOF) mass spectrometry system for applications including food safety and pharmaceuticals.

Tech transfer will drive pharma investment in Africa, says industry group

23-Apr-2015 - Technology transfer is the first step to bringing pharma investments to Africa, says the African Regulatory Network (ARN).

Synthesised Brussels sprouts chemical could be key to cancer combo drug

23-Apr-2015 - A small molecule combination therapy has shown promise in defeating breast cancers resistant to the usual treatments. 

Dispatches from Interphex

Roundup of the day’s top news at Interphex

22-Apr-2015 - The world’s top pharma and biologics manufacturing and processing companies have come together in New York this week to showcase the latest in equipment and services.

Recipharm in talks to make LIDDS' prostate cancer drug-device candidate

22-Apr-2015 - Recipharm has begun negotiations to manufacture a prostate cancer drug-device candidate for Swedish pharma firm LIDDS.

Concerns over data manipulation lands Chinese API maker with US FDA Warning

22-Apr-2015 - The US FDA has hit cancer-drug API maker Yunnan Hande Bio-Tech with a warning letter citing concerns over potential manipulation of quality test data at a plant in China.

Dispatches from CPHI Japan

Konnichiwa from Tokyo: in-Pharmatechnologist heads to CPHI Japan

22-Apr-2015 - The pharma world is converging on Tokyo this week and so are we to bring the latest news and views from the World’s second largest pharma market.


Teva bids $40bn for Mylan in proposed generics megamerger

21-Apr-2015 - A merger with Mylan would “transform the global generics space” says Teva, which has entered a $40bn bid as an alternative to the recently proposed Mylan-Perrigo deal.

US-Cuban embargo nears end as Pfizer and Regeneron make trade trip

21-Apr-2015 - Pfizer and Regeneron are in Cuba this week, scouting the country for business opportunities.

« Previous month Next month »

Key Industry Events


Access all events listing

Our events, Shows & Conferences...